Olaquindox

This classification denotes an antimalarial agent with the molecular formula C12H13N3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G3LAW9U88T, chemically known as 1,4-dihydroxy-n-(2-hydroxyethyl)-3-methyl-1.lambda.~5~,4.lambda.~5~-quinoxaline-2-carboxamide but more generally known as olaquindox, which bears US NIH Compound Identifier 71905. European Medicines Agency schedules Olaquindox in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09427MIG. The term OLAQUINDOX is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 28, No. 10 1974, List 14). OLAQUINDOX is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: CC1=C([N+](=O)C2=CC=CC=C2N1[O-])C(=O)NCCO.